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Introduction
MAPK signal transduction pathways are among the most ubiq-
uitous mechanisms of cellular regulation. The JNK family of 
MAPKs is classically activated by stresses leading to tran-
scriptional regulation and apoptotic cell death (Kyriakis and 
Avruch, 2001). JNKs are highly enriched in the nervous sys-
tem, where they play additional roles as essential regulators of 
morphogenesis during early development (Kuan et al., 1999; 
Weston et al., 2003; Xia and Karin, 2004). Interestingly, the 
identity of JNK effectors regulating brain development is not 
clear. The best-characterized target, c-Jun, appears not to be 
responsible, as c-Jun–defi  cient mice show no overt brain ab-
normality (Hilberg et al., 1993).
In addition to the well-documented proapoptotic roles of 
JNKs (Kyriakis and Avruch, 2001), JNK1-defi  cient mice dis-
play disrupted anterior commissure formation and loss of axo-
nal microtubule integrity (Chang et al., 2003). Microtubules are 
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highly enriched in the brain, where they are major determinants 
of cell shape, intracellular transport, and cell polarity. Consis-
tent with this, the list of proposed JNK functions that depend on 
microtubule structure is growing. We have previously shown 
that JNK activity regulates neuronal architecture (Coffey et al., 
2000; Björkblom et al., 2005), and studies in Caenorhabditis 
elegans suggest that the JNK pathway may regulate protein tar-
geting (Byrd et al., 2001). Nonetheless, the molecular mecha-
nisms of JNK action on the microtubule cytoskeleton remain 
elusive and the JNK substrates mediating such functions are not 
clear. Recently identifi  ed candidates include MAP2 and double-
cortin (DCX). These proteins are phosphorylated by JNK; how-
ever, it has not been established whether they mediate JNK 
action on microtubules (Chang et al., 2003; Gdalyahu et al., 
2004; Björkblom et al., 2005). We therefore took a proteomics 
approach to identify effector molecules that may explain JNK 
action on neuronal shape.
Affi  nity purifi  cation identifi  ed SCG10 as a major, brain-
derived, JNK-interacting protein (JIP). SCG10 belongs to 
a family of proteins known as stathmins, which includes stath-
min, SCG10, SCLIP, RB3, RB3′, and RB3′′. Biochemical and 
structural studies show that stathmin proteins each bind two 
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c
-Jun NH2-terminal kinases (JNKs) are essential 
  during brain development, when they regulate 
  morp  hogenic changes involving cell movement and 
  migration. In the adult, JNK determines neuronal cyto-
architecture. To help uncover the molecular effectors for 
JNKs in these events, we afﬁ  nity puriﬁ  ed JNK-interacting 
proteins from brain. This revealed that the stathmin family 
microtubule-destabilizing proteins SCG10, SCLIP, RB3, 
and RB3′ interact tightly with JNK. Furthermore, SCG10 
is also phosphorylated by JNK in vivo on sites that 
regulate its microtubule depolymerizing activity, serines 
62 and 73. SCG10-S73 phosphorylation is signiﬁ  cantly 
  decreased in JNK1−/− cortex, indicating that JNK1 
phosphorylates SCG10 in developing forebrain. JNK 
phosphorylation of SCG10 determines axodendritic length 
in cerebrocortical cultures, and JNK site–phosphorylated 
SCG10 colocalizes with active JNK in embryonic brain 
regions undergoing neurite elongation and migration. 
We demonstrate that inhibition of cytoplasmic JNK and 
expression of SCG10-62A/73A both inhibited ﬂ   uores-
cent tubulin recovery after photobleaching. These data 
suggest that JNK1 is responsible for regulation of SCG10 
depolymerizing activity and neurite elongation during 
brain development.JCB • VOLUME 173 • NUMBER 2 • 2006  266
 tubulin heterodimers and negatively regulate microtubule stabil-
ity in vitro (Horwitz et al., 1997; Charbaut et al., 2001; Ravelli 
et al., 2004). This function is inhibited upon phosphorylation of 
up to four residues or by mutations that simulate phosphoryla-
tion (Mori and Morii, 2002). Although stathmin is ubiquitously 
expressed, SCG10, SCLIP, RB3, and RB3′ are neuron-specifi  c 
proteins. Nonetheless, SCLIP, which displays 70% identity to 
SCG10, is anomalously up-regulated in a variety of human 
cancers (Walter-Yohrling et al., 2003). Interestingly, stathmin-
defi   cient mice display axonopathy in the nervous system 
(Liedtke et al., 2002), as do JNK1 knockouts (Chang et al., 
2003). The absence of a more major phenotype in these mice 
likely refl   ects functional redundancy among other stathmin 
family proteins in the nervous system. Drosophila melanogaster, 
on the other hand, possesses only a single gene encoding phos-
phoproteins bearing homology to stathmins. Disruption of this 
gene using RNAi produces serious anomalies in nervous system 
development, with migration and commissure defects in par-
ticular (Ozon et al., 2002).
We identify SCG10 as a neuron-specifi  c in vivo substrate 
for JNK and demonstrate that S73 phosphorylation of SCG10 is 
reduced in brains from mice lacking JNK1. Phosphorylation of 
SCG10 by the cytoplasmic pool of JNK controls its ability to in-
fl  uence axodendritic architecture of cortical neurons. Moreover, 
by monitoring fl  uorescent tubulin recovery after photobleach-
ing, we establish that inhibition of JNK signifi  cantly reduces 
microtubule polymerization in cultured neurons. Similarly, ex-
pression of the SCG10-AA mutant, which cannot be phosphor-
ylated by JNK, disturbs microtubule dynamics with identical 
kinetics to JNK inhibition, suggesting that JNK1 activity on 
SCG10 regulates microtubule plasticity. Consistent with this, in 
embryonic brain, the spatial distribution of JNK site–phosphor-
ylated SCG10 colocalizes with that of active JNK in regions un-
dergoing intense neuronal differentiation. These results indicate 
that negative regulation of SCG10 microtubule depolymerizing 
activity by JNK1 contributes to microtubule homeostasis and 
axondendritic growth during brain development.
Results
JIPs identiﬁ  ed by afﬁ  nity puriﬁ  cation
To identify JNK binding partners from brain, we isolated GST-
JNK1–interacting proteins from forebrain homogenate.  Affi  nity-
purifi  ed interacting proteins were separated by SDS-PAGE and 
visualized by silver staining. Bands that associated with GST-
JNK1 and not with GST alone were analyzed by matrix-assisted 
laser-desorption/ionization time-of-fl   ight mass spectrometry. 
The known JIPs GST-Pi, β-arrestin2, and ATF2 (Gupta et al., 
1995; Adler et al., 1999; McDonald et al., 2000) were identifi  ed 
as interacting with GST-JNK1 (Fig. 1). The 19-kD JNK1-
  associating protein was identifi  ed as SCG10.
SCG10, SCLIP, RB3, and RB3′ interact 
with JNK in intact cells
SCG10 belongs to a homologous family of proteins that share 
a COOH-terminal stathmin domain that is 70–80% conserved 
and an NH2-terminal sequence that is 45–70% homologous. 
Given the overall sequence similarity, we anticipated that other 
stathmin family proteins would interact with JNK. To inve-
stigate this, we coexpressed GFP-tagged stathmin, SCG10, 
SCLIP, RB3, and RB3′ with GST-JNK in COS-7 cells. JIP1 
(1–277; JNK binding domain [JBD]), a fragment of JIP1 that 
shows high-affi  nity interaction with JNK (Dickens et al., 1997), 
was used as a positive control. GFP-SCG10, -SCLIP, -RB3, 
and -RB3′ bound to GST-JNK1 after high salt washing 
(Fig. 2 A). The extent of interaction with GST-JNK1 was com-
parable to that of GFP-JBD. Parallel blots of the supernatants 
after pull down showed a corresponding depletion of JIPs, 
whereas GFP-stathmin levels remained elevated. Notably, GFP-
stathmin, which lacks an NH2-terminal extension, did not bind 
to GST-JNK1. Given the homology of the stathmin domain in 
this family, it is likely that the NH2-terminal extension is re-
quired for interaction with JNK1.
SCG10 interacts with endogenous 
JNK in brain
To determine whether SCG10 interacted stably with JNK un-
der physiological conditions, we generated SCG10 antiserum 
for coimmunoprecipitation assays. Antibody specifi  city was 
tested using COS-7 cells expressing GFP-tagged stathmins 
(Fig. 2 B). Minor cross-reactivity with GFP-RB3 was detect-
able when used for immunoprecipitation but not for immuno-
blotting. The diffuse band visible on these immunoblots is 
antibody heavy chain leached from the Sepharose beads (Fig. 
2 B, bottom). Using this serum, we demonstrated coimmuno-
precipitation from brain extract of endogenous SCG10 and 
Figure 1.  Novel and known JIPs identiﬁ   ed in rat cerebral cortex. 
To identify novel JIPs, GST-JNK1 or GST bound to Sepharose were incu-
bated with brain extract (pull downs) and associating proteins were 
  visualized by silver staining. Equal proportions of recombinant GST-
  Sepharose (lane 1), GST-Sepharose pull down (lane 2), GST-JNK1–
  Sepharose (lane 3), and GST-JNK1–Sepharose pull down (lane 4) were 
loaded. Lanes 1 and 3 contain fusion proteins that were not incubated 
with brain extract. Bands from lane 4 that did not correspond with GST-
JNK1 or associate with GST were analyzed by mass spectrometry. Iden-
tiﬁ  ed proteins are indicated.JNK1 REGULATES AXODENDRITIC LENGTH VIA SCG10 • TARARUK ET AL. 267
JNK1, the physiologically active form of JNK in brain (Fig. 
2 C; Kuan et al., 2003; Björkblom et al., 2005). Additional JNK 
isoforms also copurifi  ed with SCG10, which is indicated by an 
extra 54-kD JNK band (Fig. 2 C).
JNK phosphorylates SCG10 with higher 
speciﬁ  city than it does stathmin or SCLIP
It is notable that potential JNK phosphorylation motifs (SP) 
exist in stathmin, SCG10, and SCLIP, raising the possibility 
that these proteins are JNK substrates. It was previously shown 
that stathmin family proteins are phosphorylated in vitro by 
MAPKs (Marklund et al., 1993; Parker et al., 1998; Neidhart 
et al., 2001). However, which MAPK shows the highest ac-
tivity toward these proteins and whether they phosphorylate 
SCG10 in vivo was not known. To more closely examine 
MAPK phosphorylation specifi  city, we analyzed the kinetics 
of stathmin family protein phosphorylation (Fig. 3). We fi  rst 
determined JNK isoform–dependent phosphorylation of stath-
min family proteins, using the well-characterized JNK sub-
strate c-Jun for comparison. Although GST-stathmin and 
-SCG10 were similarly phosphorylated by JNKs (1, 2, and 3) 
at high substrate concentrations (1.6 μM), GST-SCG10 was 
the preferred JNK1 substrate at lower concentrations (0.4 μM; 
Fig. 3 A). As expected, GST-RB3 that lacks consensus JNK 
phosphorylation motifs (SP/TP) was not phosphorylated by 
JNK. A comparison of JNK phosphorylation kinetics toward 
GST-stathmin, -SCG10, and -SCLIP revealed that among the 
stathmin proteins, only GST-SCG10 is a good in vitro sub-
strate for JNK (Fig. 3 B).
The MAPKs ERK and p38 are inefﬁ  cient 
kinases for SCG10
Phosphorylation of SCG10 has not been studied as extensively 
as stathmin, though ERK, p38, and JNK were shown to phos-
phorylate bacterially expressed SCG10 in vitro (Neidhart 
et al., 2001). To determine which MAPK showed preferential 
phosphorylation of SCG10, a kinetic analysis was under-
taken (Fig. 3 C). JNK phosphorylated GST-SCG10 with fast 
kinetics, showing 40-fold higher Vmax than did ERK or p38. 
Ineffi  cient phosphorylation of GST-SCG10 by ERK and p38 
was not due to lower activity of these kinases, as the relative 
activities of JNK, p38, and ERK toward GST–c-Jun, -ATF2, 
and -Elk were comparable (Fig. 3 D). We next compared the 
relative effi  ciency of GST-SCG10 phosphorylation to known 
JNK substrates. JNK1 showed higher specifi  city toward GST-
SCG10 than it did toward the known physiological substrates 
GST–c-Jun and -Bim (Fig. 3 E), indicating that SCG10 is 
likely to be phosphorylated by JNK in vivo even when con-
centrations are limiting.
SCG10 is phosphorylated by JNK in vivo
To establish whether SCG10 could be a genuine JNK target in in-
tact cells, COS-7 cells were transfected with GFP-SCG10 in the 
presence or absence of the JNK cascade activator GFP-MLK3. 
Figure 2.  Neuron-speciﬁ  c stathmin family proteins interact with JNK in vivo. (A). To examine whether stathmin family proteins interacted with JNK in intact 
cells, GFP-tagged stathmin, SCG10, SCLIP, RB3, or RB3′ were coexpressed in COS-7 cells with GST-JNK1. GFP-JBD was a positive control for JNK binding. 
Total lysates (input), supernatants remaining after pull down (supernatant), and GST-JNK1–associating proteins (pull down) were blotted as shown. 
GFP-SCG10, -SCLIP, -RB3, and -RB3′ interacted with GST-JNK1, whereas GFP-stathmin did not. (B) To test α-SCG10 speciﬁ  city, COS-7 cell lysates expressing 
GFP-tagged stathmins were immunoblotted as shown. α-SCG10 only recognized GFP-SCG10 among stathmins. To test α-SCG10 speciﬁ  city during immuno-
precipitation, corresponding fractions were immunoprecipitated with Sepharose bound α-SCG10 and immunoblotted with α-GFP (bottom). (C) To examine 
whether endogenous SCG10 and JNK interacted in vivo, protein A–Sepharose bound α-SCG10 or protein A–Sepharose alone were incubated with brain 
extract. Associating proteins or supernatants (SN) after immunoprecipitation (IP) were immunoblotted as shown. JNK1 and additional JNK isoforms copuri-
ﬁ  ed with SCG10 from brain.JCB • VOLUME 173 • NUMBER 2 • 2006  268
Activation of JNK resulted in increased phosphorylation of 
GFP-SCG10. This phosphorylation was prevented by incuba-
tion with 3 μM (an effective concentration in intact cells) of 
the JNK inhibitor SP600125 (Fig. 4, A and B; Cao et al., 2004). 
The traditional JNK activators UV, anisomycin, and MEKK1 
also induced GFP-SCG10 phosphorylation; however, as these 
stimuli also activated ERK and p38 pathways (not depicted), 
we did not use them routinely. GFP-SCG10 phosphorylation 
was moderately induced by coexpression of GFP-MLK3. 
We postulated that the reason for such a moderate increase re-
sulted from near saturation of GFP-SCG10 phosphorylation be-
cause of the presence of GFP-MLK3 before metabolic labeling. 
We therefore compared the relative phosphorylation of HA–c-Jun 
in vivo using the same approach (Fig. 4 C). Coexpression of 
MLK3 resulted in a similar induction of HA–c-Jun phosphory-
lation (Fig. 4 C). The extent of GFP-SCG10 phosphorylation 
by JNK in intact cells compared favorably to that of the well-
characterized JNK target c-Jun. As kinases and phosphatases 
are not among the known JNK substrates, these data suggest 
that SCG10 is a direct target of JNK phosphorylation in vivo.
JNK phosphorylates SCG10 on S62 
and S73 in vivo
We identifi  ed the JNK phosphorylation sites on SCG10 (S62 
and S73) from in vitro–phosphorylated protein using mass 
spectrometry (unpublished data). To establish whether these 
sites were phosphorylated by JNK in vivo, GFP-SCG10 wild 
type (WT), or GFP-SCG10 with candidate phosphorylation 
sites, S62 and S73 mutated to alanine were expressed in COS-7 
cells together with GFP-MLK3. After metabolic labeling, GFP-
SCG10 was immunoprecipitated and digested with trypsin. Re-
sulting peptides were separated in two dimensions by thin layer 
chromatography (Fig. 4 D). GFP-SCG10 phosphopeptides 
  resolved as three spots. By individually mutating S62 and S73, we 
identifi  ed that S73 was more intensely phosphorylated by JNK 
(Fig. 4, D [middle] and E). The less intensely phosphorylated 
spots corresponded to a single peptide containing S62 (Fig. 4 D, 
right). Mutation of both sites   resulted in complete loss of GFP-
SCG10 phosphorylation,   indicating that no additional sites on 
GFP-SCG10 are phosphorylated by JNK (Fig. 4 F).
Coexpression of JIP1 enhances 
phosphorylation of SCG10 in vivo
The JIP family of scaffold proteins can facilitate JNK target 
phosphorylation by recruiting select upstream regulators, 
  including MLK3 (Whitmarsh et al., 2001). To investigate 
whether SCG10 phosphorylation by JNK was enhanced by 
  reconstitution of the JNK scaffolding machinery, we repeated 
the earlier experiments with the additional expression of GFP-
JNK and -JIP1 (Fig. 4 G). GFP-SCG10 phosphorylation was en-
hanced threefold by addition of GFP-JIP1 (Fig. 4 H). Together, 
these results show that GFP-SCG10 phosphorylation by GFP-
JNK is amplifi  ed but is not dependent on the expression of exog-
enous GFP-JIP1.
Figure 3.  SCG10 is preferentially phosphory-
lated by JNK, with Km values similar to known 
JNK substrates. (A) To examine whether stath-
mins were phosphorylated by JNK, bacterially 
expressed GST-stathmin, -SCG10, and -RB3 at 
ﬁ  nal concentrations of 1.6 and 0.4 μM were 
phosphorylated by recombinant active JNKs 
in vitro. GST–c-Jun(5–89) was used as a control. 
Representative autoradiographs are shown. 
The Coomassie-stained gel shows equal pro-
tein loading (bottom). (B) A kinetic analysis 
of phosphate incorporation was performed to 
examine JNK substrate preference. Quantita-
tive data of JNK-dependent phosphate transfer 
to GST-tagged SCG10, stathmin, and SCLIP 
is shown. SCG10 phosphorylation by JNK1 
showed substantially higher Vmax and lower Km 
values than did stathmin and SCLIP. (C) To elu-
cidate which of the MAPKs was the preferred 
kinase for SCG10, active recombinant JNK1, 
ERK, and p38 were used for a comparative 
analysis of SCG10 phosphorylation. (D) An 
autoradiograph depicting phosphorylation 
of GST–c-Jun(5–89), -Elk(205–428), and 
-ATF2(1–109) by preferred kinases JNK, ERK, 
and p38 is shown. This shows that the activity 
of kinase preparations used in C were compa-
rable. (E) Km values for MAPK phosphorylation 
of GST–c-Jun, -SCG10, -Bim, -ATF2, and -Elk 
were calculated from Lineweaver-Burk plots. 
The Km value for GST-SCG10 phosphorylation 
by JNK compares well to those of the better-
characterized JNK targets c-Jun and Bim.JNK1 REGULATES AXODENDRITIC LENGTH VIA SCG10 • TARARUK ET AL. 269
SCG10 S73 phosphorylation is depleted 
in JNK1−/− cortex
If JNK plays a mandatory role in phosphorylating SCG10 and 
thereby controls its activity, JNK site phosphorylation of SCG10 
should be reduced in JNK-defi  cient mice. To examine this, we gen-
erated antiserum against the major in vivo JNK phosphorylation 
site on SCG10, S73. After affi  nity  purifi   cation, this antibody 
(PSCG10) recognized only the phosphorylated form of SCG10 
(Fig. 5 A [left] and Fig. S1, available at http://www.jcb.org/cgi/
content/full/jcb.200511055/DC1) and showed acceptable specifi  c-
ity by immunoblotting (Fig. 5 A, right). To examine the importance 
of JNK for SCG10 phosphorylation in developing brain, cortex 
from JNK-defi  cient mice was immunoblotted with antibodies de-
tecting SCG10 and PSCG10 (Fig. 5 B). JNK site phosphorylation 
of SCG10 was reduced by  50% in brains from JNK1−/− mice 
(Fig. 5 C) and to a lesser extent in JNK2- and JNK3-defi  cient mice. 
A parallel analysis of JNK activity shows that JNK1 is the domi-
nant active form in developing brain (Fig. 5 D).
SCG10 and JNK1 site–phosphorylated 
SCG10 localize to regions of elevated 
JNK activity in fetal brain
If SCG10 is a genuine JNK target in brain, its regional ex-
pression profi   le should overlap at least partially with that 
of JNK1, the constitutively active form of JNK in the brain. 
SCG10 expression is maximal during embryonic development 
(Stein et al., 1988), although its precise location and function 
in developing brain was unknown. Examination of SCG10 and 
JNK1 immunoreactivity in embryonic brain showed a strik-
ingly similar expression pattern that contrasted markedly to 
that of the glial cell intermediate fi  lament protein (GFAP; Fig. 
6 A). JNK1 and SCG10 expression was mid to low through-
out the midbrain, with more prominent staining in the telen-
cephalon (developing cortex), the midbrain roof, the olfactory 
epithelium, the inferior colliculus, and the medulla oblon-
gata (Fig. 6 A; see Fig. S2, available at http://www.jcb.org/
cgi/content/full/jcb.200511055/DC1, for magnifi  ed  views). 
Close inspection of the telencephalon revealed concentrated 
JNK1 and SCG10 staining in the intermediate zone, which has 
the highest density of postmitotic neurons (Fig. 6, C and D). 
Similarly, phospho-JNK (PJNK) and JNK1 site–  phosphorylated 
SCG10 localized in the same region as did class III 
β-tubulin, a marker for early differentiating neurons (Fig. 6 D).
In contrast, the ventricular zone, the location of neuronal precur-
sors, showed only an occasional ribbon-like staining pattern for 
PJNK, JNK1, and SCG10, possibly corresponding to radially 
migrating early differentiated neurons (Fig. 6 D). These obser-
vations were confi   rmed by microdissection followed by immuno-
blotting (Fig. 6 E). At the subcellular level, JNK1, PJNK, 
SCG10, and S73-phosphorylated SCG10 immunoreactivity 
were cytosolic (Fig. 6 D). This suggests that JNK signaling 
has functions in the cytoplasm during brain development in 
Figure 4.  SCG10 is phosphorylated by JNK 
in intact cells. (A) To determine whether SCG10 
is a substrate for JNK in vivo, COS-7 cells ex-
pressing GFP-SCG10 ± GFP-MLK3 to activate 
JNK were labeled with 
32P ± 3 μM of the JNK 
inhibitor SP600125. A representative auto-
radiograph of GFP-SCG10 phosphorylation is 
shown (top), as is an immunoblot of corre-
sponding samples (bottom). (B) Quantitative 
data for three sets, mean ± SEM. (C) For com-
parison, phosphorylation of HA–c-Jun by JNK 
was examined under identical conditions. An 
autoradiograph of the resulting gel is shown. 
(D) COS-7 cells were transfected with GFP-
SCG10-WT, GFP-SCG10-S62A, or GFP-
SCG10-S73A  ± GFP-MLK3. Samples were 
analyzed by 2D-phosphopeptide mapping. 
Representative autoradiographs are shown. 
GFP-SCG10-WT resolved as three phospho-
peptide spots (left), GFP-SCG10-S62A as one 
spot (middle), and GFP-SCG10-S73A as two 
spots (right; partial cleavage). S62- and S73-
phosphorylated peptides are indicated by ar-
rows and arrowheads, respectively. (E) The 
induction by JNK of SCG10 S62/S73 phos-
phorylation was measured from two sets of 
phosphopeptide maps. Means are shown. 
(F) To evaluate whether JNK phosphorylated 
GFP-SCG10 on additional sites, GFP-SCG10-
WT or a S62A/S73A mutant was coexpressed 
with GFP-MLK3. SCG10 phosphorylation was 
measured. A representative autoradiograph 
(top) and immunoblot (bottom) of immunopre-
cipitated GFP-SCG10 are shown. (G) To ex-
amine whether the JNK scaffold protein JIP1 
enhanced SCG10 phosphorylation, COS-7 
cells were transfected with GFP-SCG10, -JIP1, 
-JNK, and -MLK3. A representative autoradiograph is shown (top). Total lysates were immunoblotted with antibodies recognizing PJNK (middle) and GFP (bottom). 
Reconstitution of the JIP1 scaffolding complex enhanced SCG10 phosphorylation threefold. (H) Means ± range from two datasets are shown.JCB • VOLUME 173 • NUMBER 2 • 2006  270
  addition to the previously described regulation of nuclear 
events (Weston et al., 2003).
Active JNK and JNK1 site–phosphorylated 
SCG10 localize to punctate structures 
on neuronal processes
We previously reported that neuronal JNK1 activity is constitu-
tively elevated and resides in the cytoplasm of neurons differen-
tiating in culture (Coffey et al., 2000; Björkblom et al., 2005). 
We show that SCG10 and JNK1 associate tightly in vivo and in 
vitro (Figs. 1 and 2). To examine whether S73-phosphorylated 
SCG10 localized with active JNK, cortical neurons in culture 
were stained with PJNK, SCG10, PSCG10, and tubulin anti-
bodies (Fig. 7 A). SCG10 resided in the Golgi apparatus and 
growth cones but also displayed conspicuous punctate staining 
in the cytoplasm as previously shown (Lutjens et al., 2000; 
  Gavet et al., 2002). PSCG10 and PJNK showed strikingly similar 
staining in the neurites and, unlike SCG10, PJNK and PSCG10 
immunoreactivity were not elevated at the Golgi compartment. 
To examine whether S73-phosphorylated SCG10 and PJNK in-
deed colocalized in vesicles, membrane fractions were prepared 
from postnatal day 7 brain. Although total brain JNK was pres-
ent in both soluble and membrane fractions, active JNK, 
SCG10, and S73-phosphorylated SCG10 concentrated in the 
P2 fraction, containing predominantly endosomal and Golgi 
vesicles (Fig. 7 B).
Characterization of a cytosol-speciﬁ  c 
JNK inhibitor
To test the infl  uence of cytosolic JNK on neuritic architecture 
without interference from nuclear JNK, we analyzed the effi  -
cacy of a cytosol-targeted JNK inhibitor. GFP-NES-JBD expres-
sion reduced the phosphorylation of a cytoplasmic JNK target 
(NES-Jun) in cortical neurons (Fig. 8, A and B) and blocked
JNK phosphorylation of recombinant GST–c-Jun (Fig. 8 C). 
Conversely, GFP-NES-JBD did not inhibit transcriptional 
  activation of GAL4-Jun after withdrawal of trophic support 
(Fig. 8 D). Together, these data indicate that NES-JBD selec-
tively blocks JNK from phosphorylating cytoplasmic targets.
JNK phosphorylation of SCG10 regulates 
neurite length
Tight regulation of microtubule dynamics is an essential deter-
minant of axonal length. The known function of SCG10 as a 
microtubule disassembly factor made it a good candidate for 
mediating JNK regulation of neuronal shape. As active JNK 
concentrated in cortical regions undergoing differentiation, we 
examined the effect of JNK on neurite length in cortical neurons 
expressing CFP-tagged SCG10 variants (Fig. 9). The JNK site–
phosphorylation mutants CFP-SCG10-AA (S62A/S73A), which 
cannot be phosphorylated by JNK, and CFP-SCG10-DD (S62D/
S73D), which mimics JNK-phosphorylated SCG10, were used. 
The expression levels of SCG10 variants did not differ between 
samples (Fig. 9 E and Fig. S3, available at http://www.jcb.
org/cgi/content/full/jcb.200511055/DC1).
Mutation of S62/S73 to alanine enhances tubulin depoly-
merizing activity, whereas mutation to phosphomimicking as-
partates inhibits it (Antonsson et al., 1998). Consistent with this, 
we observed a 25% reduction in axonal length in cortical neu-
rons expressing SCG10-AA for 48 h (Fig. 9, A–D). Under the 
same conditions, total process length decreased by 30%, indicat-
ing that axonal and dendritic compartments were both affected. 
This is consistent with the proposed axodendritic expression of 
SCG10 (Gavet et al., 2002). Cells expressing CFP-SCG10-WT 
grew axons of normal length that did not differ signifi  cantly from 
cells expressing CFP alone. This was as expected because of the 
elevated JNK activity in cortical neurons (Fig. 5 D; Björkblom 
et al., 2005), which phosphorylates S62 and S73 (Fig. 5 D), leading 
Figure 5.  SCG10 S73-phosphorylation is decreased in JNK1−/− cortex. (A, left) Antibodies raised against S73-phosphorylated SCG10 (PSCG10) were 
tested against GFP-SCG10 that was not phosphorylated (DeP-SCG10) or phosphorylated (PSCG10) with active JNK. (right) The speciﬁ  city of α-PSCG10 to-
ward cortical neurons or brain extract was tested by immunoblotting. (B) Cortex from 7-d JNK-deﬁ  cient mice (JNK1−/−, JNK2−/−, JNK3−/−, and 
JNK2−/−3−/−) was immunoblotted with PSCG10, SCG10, and JNK1/2 recognizing antibodies. (C) PSCG10 immunoreactivity was normalized to 
SCG10 expression and expressed as a percentage of WT tissues. (D) PJNK immunoreactivity was quantiﬁ  ed from brain extracts. Means ± SEM are shown 
for three separate sets of animals (*, P < 0.05; ***, P < 0.005; determined by a t test).JNK1 REGULATES AXODENDRITIC LENGTH VIA SCG10 • TARARUK ET AL. 271
to inhibition of its activity (Antonsson et al., 1998). Similarly, 
cells expressing the functionally inactive, pseudophosphorylated 
mutant (CFP-SCG10-DD) extended processes of normal length. 
Notably, inhibition of cytoplasmic JNK using NES-JBD reduced 
neurite length, similar to CFP-SCG10-AA. These data suggest 
that endogenous SCG10 may mediate the determination of axo-
dendritic length by JNK. To further test the implication that other 
JNK effectors were responsible, we expressed CFP-SCG10-
DD together with NES-JBD. Inhibition of JNK with NES-JBD 
failed to infl  uence neurite length in the presence of the pseudo-
phosphorylated CFP-SCG10-DD mutant. This excludes the pos-
sibility that other JNK effectors were responsible. The ability 
of CFP-SCG10-DD to rescue the phenotype induced by NES-
JBD suggests that JNK regulation of neurite length is   mediated 
by SCG10.
JNK and SCG10 regulate microtubule 
dynamics in cortical neurons
If JNK negatively regulates SCG10 function, then inhibition 
of cytosolic JNK or expression of an active SCG10 mutant 
(CFP-SCG10-AA) should have a similar effect on microtubule 
dynamics. To test this, we measured microtubule turnover in 
cortical neurons (Fig. 10). To monitor microtubule dynamics in 
living neurons, we expressed α-tubulin fused to Venus, a variant 
of YFP (Nagai et al., 2002). Neurites of cells expressing Venus–
α-tubulin were photobleached to the extent that 80% of the ini-
tial fl  uorescence was destroyed. Recovery of Venus–α-tubulin 
into the bleached region was measured. Coexpression of the 
JNK inhibitor GFP-NES-JBD reduced Venus–α-tubulin recov-
ery, as did expression of SCG10-AA. Kinetic modeling revealed 
a 50% decrease in the mobile fraction of Venus–α-tubulin upon 
JNK inhibition or SCG10-AA expression (Fig. 10, C and D). 
This is consistent with our proposal that SCG10 mediates the 
effect of JNK on microtubule dynamics.
Discussion
Microtubules are fundamental components of the eukaryotic 
cytoskeleton. They confer cell shape and polarity and regulate 
movement, neurite extension, and cell division. They also permit 
Figure 6.  Expression of JNK1 and SCG10 overlap spatially in developing mouse brain. If SCG10 is a physiological target for JNK, it should localize re-
gionally with active JNK. (A) To test this, sagittal sections of embryonic day (E) 15.5 mouse embryos were immunostained with antibodies recognizing 
JNK1, SCG10, and GFAP or with preimmune serum for SCG10. Immunoreactivity was detected with 3,3′-diaminobenzedine tetrahydrochloride (brown) 
and counterstained with hematoxylin (blue). Regions displaying prominent expression of JNK1 and SCG10 are indicated. TE, telencephalon; OE, olfactory 
epithelium; MB, roof of the midbrain; IC, inferior colliculus; MO, medulla oblongata. Bar, 500 μm. (B) Speciﬁ  city of the antibodies toward forebrain extract. 
(C) The telencephalon is divided into the marginal zone (MZ), cortical plate (CP), intermediate zone (IZ), and ventricular zone (VZ) as indicated. Bar, 
200 μm. (D) Closer inspection of the telencephalon conﬁ  rms that SCG10, JNK1, PJNK, PSCG10, and class III β-tubulin (TuJ1) immunoreactivity localizes 
to the intermediate zone, cortical plate, and marginal zone (arrows) and is predominantly cytosolic (bottom; arrows). Preincubation of α-PSCG10 with 
phospho-S73 antigenic peptide blocks immunoreactivity. Bar, 50 μm. (E) To verify that the immunoreactivity observed corresponded to the antigens tested, 
multiple sections of the cortical plate, intermediate zone, and ventricular zone were microdissected and levels of JNK1, PJNK, and SCG10 examined by 
immunoblotting. Protein loading is indicated by Coomassie staining of histones.JCB • VOLUME 173 • NUMBER 2 • 2006  272
delivery of cargo to and from the cell periphery. Underlying 
each of these cellular events is the dynamic assembly and disas-
sembly of tubulin (Dent and Gertler, 2003). Microtubule stabil-
ity is augmented by the binding of microtubule-associated
proteins and decreased by destabilizing proteins such as stathmins. 
Neurite elongation requires a fi  ne balance between microtubule 
stability and plasticity. Too much or too little stabilization re-
tards neurite extension (Chuckowree and Vickers, 2003). Thus, 
the activity of destabilizing factors must be tightly regulated 
to enable extension. The activities of microtubule regulatory 
proteins are affected by phosphorylation, and inappropriate ex-
pression and phosphorylation of these proteins are hallmarks 
of cancer and neurodegenerative diseases (Walter-Yohrling 
et al., 2003; Stoothoff and Johnson, 2005). In spite of this 
knowledge, it remains unclear which are the pivotal protein 
  kinases determining the activities of these microtubule regulators. 
JNK1 has recently been implicated in regulating microtubule 
integrity in the nervous system. Thus, mice lacking this kinase 
display decreased microtubule polymer length, axonal commis-
sure defects (Chang et al., 2003), and disturbed dendritic archi-
tecture (Björkblom et al., 2005). These architectural anomalies 
are believed to be mediated via phosphorylation of the microtubule-
stabilizing protein MAP2; however, additional JNK1 effectors 
have not been excluded.
JNK1 and SCG10 regulate microtubule 
dynamics in differentiating neurons
We demonstrate that SCG10 is phosphorylated on S62 and S73 
by JNK in intact cells. We investigate the functional importance 
of this phosphorylation on microtubule dynamics in vivo using 
FRAP. Expression of an SCG10 mutant that cannot be phosphor-
ylated by JNK (CFP-SC10-AA) dramatically inhibits  microtubule 
Figure 7.  Active JNK and S73-  phosphorylated 
SCG10 colocalize in vesicular fractions. 
(A) Confocal sections of cortical neurons at 1 d 
in vitro immunostained for SCG10, PSCG10, 
and PJNK (green) and for β-tubulin (red) re-
vealed conspicuously punctate immunoreactiv-
ity in the neurites. Corresponding staining in 
the absence of 1° antibody (−1°αr) is shown. 
Golgi (arrow) and growth cone–localized 
SCG10 (arrowheads) are indicated. The 
speciﬁ  city of α-PSCG10 for immunostaining is 
shown in Fig. S1 (available at http://www.jcb.
org/cgi/content/full/jcb.200511055/DC1). 
Bar, 10 μm. (B) To examine whether SCG10 
and active JNK colocalized in vesicles, rat 
forebrain was fractionated. Homogenate (H) 
was centrifuged at 800 g to isolate intact cells 
and nuclei (P1). The remaining supernatant 
(S1) was centrifuged at 16,000 g to yield a 
pellet containing endosomal and Golgi frac-
tions (P2) and supernatant (S3). The ﬁ  nal pellet 
(P3) contains plasma membranes.JNK1 REGULATES AXODENDRITIC LENGTH VIA SCG10 • TARARUK ET AL. 273
turnover. Inhibition of the cytoplasmic pool of JNK is as effec-
tive in disrupting microtubule dynamics as the phosphorylation 
site mutant. Both conditions reduce the mobile fraction of fl  uo-
rescent tubulin by 50%. Interestingly, there is a 50% recovery of 
Venus–α-tubulin that persists under conditions when JNK is 
  inhibited or SCG10 is active. This recovery, which displays 
a half-life of 200 s, may be due to slow diffusion of Venus–
α- tubulin:β-tubulin dimers. Tubulin has many binding partners 
within cells, and the soluble pool of fl  uorescent tubulin may be 
low, leading to a slower diffusion rate than expected based on 
size alone.
JNK1 is the predominant active form of JNK in cortical 
neurons and it resides in the cytoplasm, as we have previously 
reported in other neuronal types (Coffey et al., 2002; Björkblom 
et al., 2005). We show that JNK1 phosphorylates S73 of SCG10 
in developing brain. However, published data shows that, at 
high-kinase concentrations, SCG10 is equally phosphorylated 
by ERK, p38, and JNK3 in vitro (Neidhart et al., 2001). We 
fi  nd that ERK and p38 phosphorylated SCG10 very poorly 
under conditions that favor kinase substrate specifi  city and, 
furthermore, that JNK1 phosphorylates S73 in brain, whereas 
JNK3 plays only a minor role. Our data suggest that JNK1 and 
SCG10 cooperate in developing neurons to determine micro-
tubule turnover.
Active JNK stabilizes the neuritic 
shaft during outgrowth, and SCG10 
phosphorylation may be pivotal
Turnover of microtubules occurs along the length of the neurite 
(Lim et al., 1990). We show that overexpression of a functionally 
active SCG10 mutant (GFP-SCG10-AA) hinders microtubule 
recovery in this region. Endogenous SCG10, on the other hand, 
is abundantly distributed in punctae throughout the neurites in 
resting neurons, yet microtubule homeostasis is not disturbed. 
Therefore, SCG10 activity in neurites must be tightly controlled. 
Consistent with this, we fi  nd that in this region, SCG10 is phos-
phorylated on S73, which is suffi  cient to inactivate the protein 
(Antonsson et al., 1998). To extend long axons and dendrites, 
neurons must exert precise control over the dynamics of micro-
tubules, and inadvertent disassembly along the neurite would 
impede outgrowth (Dent and Gertler, 2003). We show that JNK 
can confer this essential stabilizing infl  uence to growing neu-
rites. We propose that JNK1, by phosphorylating SCG10 locally 
within the neurite, represses inappropriate destabilizing events. 
Such a role for JNK1 in fi  ne-tuning SCG10 activity in the devel-
oping nervous system may be widespread, as active JNK 
and JNK site–phosphorylated SCG10 localize regionally in 
 embryonic  brain.
JNK regulation of SCG10 phosphorylation appears to be 
confi   ned to distinct subcellular compartments. For instance, 
there is no prominent PJNK immunoreactivity at the Golgi 
complex (unpublished data). Similarly, there is a striking ab-
sence of concentrated S73-phosphorylated SCG10 immuno-
reactivity at the Golgi, despite the clear presence of SCG10. This 
suggests that SCG10 may be active in this region. However, it is 
also possible that Golgi-localized SCG10 is phosphorylated on 
a separate site, leading to inactivation. The function of SCG10 
at the Golgi is not reported and may require some effort to elu-
cidate. On the contrary, in growth cones, SCG10 is believed to 
be active, and this activity is required for neurite extension (Suh 
et al., 2004). In spite of this, we detect moderate levels of inac-
tive S73-phosphorylated SCG10 in growth cones. However, the 
proportion of phosphorylated SCG10 at the growing tips is low 
relative to total SCG10, suggesting that the dephosphorylated 
active form may be enriched here. Consistent with this, PJNK 
does not concentrate in growth cones (unpublished data). 
Together, these fi  ndings suggest that in contrast to neurites, 
where we show that JNK maintains microtubule stability, JNK 
is inactive in areas undergoing dynamic growth. The character-
istic triangular shape of growth cone–localized active SCG10 
shown in young neurons suggests that it extends into the lamel-
lipodia, where it could contribute to motility by repressing rigid 
microtubule formation. Consistent with this idea, active stath-
min has been shown to concentrate in the highly motile lamelli-
podia of migrating cells (Niethammer et al., 2004).
JNK1 and SCG10 are likely partners 
during brain development
Normal brain morphogenesis requires functional JNK at criti-
cal events during development, including closure of the neural 
tube (Kuan et al., 1999), migration of telencephalic neurons 
(Hirai et al., 2002), and development of the optic fi  ssure and 
eye lens (Weston et al., 2003). The consequences of interfer-
ing with the cytosolic pool of physiologically active JNK are 
disturbed stability of the microtubule cytoskeleton and stunted 
neurite growth (Figs. 9 and 10). Yet, the JNK targets mediating 
these events are unclear. SCG10 is a good candidate for mediat-
ing JNK regulation of microtubule homeostasis in embryonic 
Figure 8.  NES-JBD selectively blocks cytosolic JNK in cortical neurons. 
The compartmental speciﬁ  city of GFP-NES-JBD was tested. (A) 1-d-old corti-
cal neurons were transfected with the JNK inhibitor pEGFP-NES-JBD and 
pEGFP–NES–c-Jun as shown. Samples were immunoblotted with phospho–
S63–c-Jun (P–c-Jun) or GFP antibodies. (B) Quantitative data from A, show-
ing means ± SEM (n = 3). (C) Cortical neurons were transfected with 
pEBG-JNK1, pEGFP-NES-JBD, and pECFP-SCG10. GST-JNK1 was isolated 
and kinase activity toward recombinant GST–c-Jun measured. (D) To test 
whether GFP-NES-JBD interfered with nuclear events, cerebellar granule 
neurons were transfected with a GAL4-luciferase reporter, GAL4–c-Jun
(5–105), Renilla luciferase internal control, and pEGFP-NES-JBD or empty 
vector (pCMV) as indicated. Trophic withdrawal was for 4 h. Fireﬂ  y luciferase 
normalized to Renilla luciferase activity was expressed as arbitrary units. 
Means ± SEM (n = 3) are shown. GFP-NES-JBD did not inhibit nuclear 
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brain. Its expression peaks during embryogenesis (Stein et al., 
1988), when we show that JNK1 site–phosphorylated SCG10 
colocalizes with active JNK in the intermediate zone of the de-
veloping cortex. Neurons in the intermediate zone migrate radi-
ally from their place of origin in the ventricular zone, through 
the layers generated earlier, to form the cortical layers that fi  -
nally make up the mature cortex. To accomplish this, neurons 
extend elongated processes that are rich in class III β-tubulin. 
JNK is implicated in regulating microtubules in the intermedi-
ate zone at this developmental stage (Hirai et al., 2002). Simi-
larly, the SCG10 homologue in D. melanogaster (D-stathmin) 
is associated with neurite elongation during embryogenesis 
(Ozon et al., 2002). Thus, it is likely that the colocalization of 
JNK1 with JNK1 site–phosphorylated SCG10 to this region is 
functionally important.
Alternative mediators of JNK action
Alternative JNK substrates that could contribute to the neu-
ronal shape changes described are MAP2 and DCX. Both 
proteins function to stabilize microtubules. High molecu-
lar weight MAP2 is a likely JNK effector maintaining den-
dritic architecture in the brain (Björkblom et al., 2005), 
although it is unlikely to mediate JNK regulation of axonal 
length in developing cortex, as it is dendrite specifi  c and ex-
pressed in mature neurons. DCX, on the other hand, is ex-
pressed in embryonic brain and resides, like SCG10, in the 
inter  mediate zone of the developing telencephalon (Gdalyahu 
et al., 2004). However, the impact of JNK on DCX regulation of 
microtubules is not known. Our model proposes that JNK phos-
phorylation of SCG10 reduces microtubule depolymerizing ac-
tivity in the neuritic shaft, where microtubules are more stable 
(Li and Black, 1996), and is required for neurite elongation. 
The functional signifi  cance of JNK interaction with the   neural-
enriched stathmin family members SCG10, SCLIP, RB3, and 
RB3′ is not yet clear. It is unlikely to be signifi  cant during 
early brain development, as expression of SCLIP and RB3 in-
crease postnatally (Mori and Morii, 2002). However, in adult 
RB3, expression like JNK activity is induced after seizures in 
the hippocampus (Beilharz et al., 1998; Mielke et al., 1999), 
where JNK activation precedes RB3 induction. Whether these 
proteins cooperate in functional plasticity changes during 
learning and memory remains to be seen.
The JNK family of protein kinases is a central control 
point of cell fate in disease and physiological situations. It is 
only relatively recently that researchers have realized that 
they may also have additional physiological functions in the 
central nervous system (Coffey et al., 2000; Byrd et al., 2001; 
Chang et al., 2003; Weston et al., 2003; Björkblom et al., 
2005), indicat  ing that we must reach an understanding of pre-
cisely how JNKs participate in disease mechanisms on the 
one hand and homeostatic, developmental, and regenerative 
mechanisms on the other. Key to this understanding is a 
  detailed knowledge of JNK effectors mediating physiological 
responses in the brain. We identify SCG10, a microtubule 
  depolymerizing factor, as an in vivo substrate for JNK on 
sites that regulate its destabilizing activity. Our data indicate that 
Figure 9.  Cytoplasmic JNK controls SCG10 
regulation of neurite length. (A) The effect of 
JNK1 site–phosphorylated SCG10 on neuro-
nal morphology was assessed by transfecting 
cortical neurons 1 d after plating with pECFP, 
pECFP-SCG10, pECFP-SCG10-AA, pECFP-
SCG10-DD, and pGFP-NES-JBD as indicated. 
Samples were cotransfected with pEYFP-CAAX 
as a transfection marker and counterstained 
with Hoechst 33342. Only viable cells with 
detectable expression of YFP and CFP were 
counted. YFP images were analyzed. Axon 
length refers to the length of the longest cell 
process. The number of cells analyzed is indi-
cated above the histogram bar. (B) Total neu-
rite length refers to the combined length of 
processes from a given cell. Means ± SEM from 
4–8 experimental sets are shown (*, P < 0.02; 
**, P < 0.001; determined by paired 
t test). (C) Representative images of EYFP-CAAX 
ﬂ  uorescence. Cells expressing CFP-SCG10-AA 
or CFP-SCG10 and GFP-NES-JBD show re-
duced process length, whereas cells ex  pressing 
CFP-SCG10-DD (mimicking JNK phosphoryla-
tion) extend long processes even in the pres-
ence of a JNK inhibitor. (D) The distribution of 
axonal length is shown. (E) To examine the rel-
ative expression of CFP-tagged SCG10, 
SCG10-AA, and SCG10-DD, neurons were 
transfected as in A–D and lysates were immuno-
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phosphorylation of SCG10 by JNK can play an unequivocal 
role in maintaining neuronal   microtubule stability and   effi  cient 
neurite elongation.
Materials and methods
Plasmid construction
Rat stathmins and α-tubulin were isolated by PCR from rat cerebellar gran-
ule neuron cDNA and inserted into pEGFP-C1, pECFP-C1, pEYFP-C1 
(CLONTECH Laboratories, Inc.), Venus-encoding vector (a gift from A. Miy-
awaki, Institute of Physical and Chemical Research, Saitama, Japan), 
pEBG (a gift from B. Mayer, Children’s Hospital, Boston, MA), and pGEX-
KG (a gift from J. Kyriakis, Massachusetts General Hospital, Boston, MA) 
vectors as described previously (Coffey et al., 2002). ECFP-tagged SCG10 
phosphorylation site mutants S73A, S62A, S62A/S73A, S62D, S73D, 
and S62D/S73D were prepared by insertional overlapping PCR using 
  mutagenic and ﬂ  anking primers. The pEBG-JNK1, JNK2, JNK3, pEGFP-
MEKK1∆, pcDNA3-GAL4-Jun(5–105), and pGL3-G5E4△38 constructs 
were described previously (Coffey et al., 2000, 2002; Hongisto et al., 
2003). pEGFP-JIP-JBD, NES–c-Jun(1–146), and MLK3 were constructed by 
PCR-based methods from pcDNA3-mJIP1a, pMT108, and HeLa cDNA, re-
spectively. c-Jun(5–89), JNK1, ATF2(1–109), and Elk1(205–428) in pGEX, 
ERK, and p38 in pEBG, pEF-EE-Bim-EL, and pCMV were gifts from J. Woodgett 
(Ontario Cancer Institute, Toronto, Canada), R. Davis (Howard Hughes 
Medical Institute, Worcester, MA), A. Sharrocks (University of Manchester, 
Manchester, UK), B. Mayer, D. Huang (The Walter and Eliza Hall Institute 
of Medical Research, Melbourne, Australia), and S. van den Heuvel 
  (Massachusetts General Hospital, Boston, MA), respectively. The coding 
sequence for Bim was cut from pEF-EE-Bim-EL and inserted into pGEX-KG.
Recombinant protein preparation
Recombinant c-Jun, ATF2, Elk, Bim, and stathmins were prepared from 
bacterial extracts as described previously (Courtney and Coffey, 1999; 
Coffey et al., 2000). Recombinant active JNK1, JNK2, JNK3, p38, and 
ERK were prepared as described previously (Hongisto et al., 2003).
Afﬁ  nity puriﬁ  cation and mass spectrometry
For afﬁ  nity puriﬁ  cation of JIPs, postnatal day 7 rat cortex was homoge-
nized in lysis buffer (20 mM Hepes, pH 7.4; 2 mM EGTA; 50 mM 
β-  glycerophosphate; 1 mM DTT; 1 mM Na3VO4; 1% Triton X-100; 10% 
glycerol; 50 mM NaF; 1 mM benzamidine; 1 μg/ml aprotinin, leupeptin, 
and pepstatin; and 100 μg/ml PMSF) with an ultra-turrax (IKA) and a 
27-gauge needle and centrifuged for 15 min at 10,000 g at 4°C to   remove 
insoluble material. 10 mg/ml of extract was incubated with 100 μg of 
GST coupled to glutathione–Sepharose for 1 h at 4°C. Precleared extract 
was rotated overnight at 4°C with 100 μg of GST-JNK1 conjugated to 
Figure 10.  JNK and SCG10-S62/S73 phos-
phorylation regulate microtubule dynamics. 
(A) Representative time-lapse images of cortical 
neurons expressing Venus–α-tubulin, Flag-JBD, 
and CFP-SCG10-AA as shown before (121 s) 
directly after (192 s), and 25 min (1764 s) 
after photobleaching (arrow). The bleached 
region is highlighted (red). (B) Quantitated 
ﬂ  uorescence in the bleached zone, corrected 
for background and normalized to prebleach 
intensity, is shown. Means from 3–4 separate 
experiments are shown. (C) Fitted curves of 
ﬂ  uorescence recovery (mean of 3–4 datasets). 
(D) Mobile fraction of Venus–α-tubulin derived 
from kinetic plots. Means ± SEM (n = 3–4) 
are shown.JCB • VOLUME 173 • NUMBER 2 • 2006  276
  glutathione–  Sepharose (Sigma-Aldrich). Immobilized proteins were washed 
in 2× lysis buffer, 3× LiCl buffer (100 mM Tris, pH 7.6, 0.5 M LiCl, 0.1% 
Triton X-100, and 1 mM DTT), and 2× lysis buffer. Equal proportions were 
separated by SDS-PAGE and visualized by silver staining. For identiﬁ  cation 
of JNK1-interacting proteins, in-gel digestion was performed as described 
previously (Björkblom et al., 2005) and analyzed by matrix-assisted laser-
desorption/ionization time-of-ﬂ  ight using a Voyager DE PRO. Peptide mass 
ﬁ  ngerprints were analyzed with Mascot (Matrix Science).
Antibody preparation
Polyclonal antibodies were raised against bacterially expressed GST-
SCG10 and against the phosphopeptide EAPRTLAS(PO3)P  K  K  K  D  L  S  L  E  E  . 
Phosphospeciﬁ  c antibodies were afﬁ  nity puriﬁ  ed sequentially on phospho- 
and dephosphopeptide columns.
Protein phosphorylation analysis
Transfected COS-7 cells were serum starved overnight (0.1% FCS) and in-
cubated in phosphate-free Eagle’s minimum essential medium (Sigma-
  Aldrich) for 2 h. ATP pools were isotopically labeled by incubating cells 
with 0.5 mCi/ml [
32P]phosphate for 2 h at 37°C and 5% CO2. Cells were 
washed with PBS, lysed in lysis buffer, and centrifuged at 13,000 rpm and 
4°C for 10 min. Supernatants were immunoprecipitated using cross-linked 
SCG10 antiserum (5 μl) or with anti-HA (5 μl; Santa Cruz Biotechnology, 
Inc.). Phosphorylated proteins were visualized by autoradiography. Phospho-
SCG10 was excised from the gel and trypsinized overnight at 37°C. Tryp-
tic digests were separated by 2D-TLC with electrophoresis, pH 1.9, 
followed by ascending chromatography, pH 3.5. TLC-separated phospho-
peptides were quantiﬁ  ed by phosphorimaging. For in vitro analysis, active 
recombinant JNKs were used to phosphorylate bacterially puriﬁ  ed GST fu-
sion proteins using γ-[
32P]ATP as described previously (Coffey et al., 2000; 
Hongisto et al., 2003). Kinetic analyses were performed as described pre-
viously (Björkblom et al., 2005).
Cell culture, transfection, and morphological analysis
Cortical neuron cultures were prepared as described previously (Björkblom 
et al., 2005). Cells for morphological analysis were plated at a density of 
0.5 × 10
6. 24 h after plating, cells were transfected using Lipofectamine 
2000 (Invitrogen) with 25% of total DNA as pEYFP-CAAX, 25% pECFP-
C1, or ECFP-tagged SCG10 WT, S62A/S73A, or 62D/S73D and 50% 
pEGFP-NES-JBD as indicated. Cells were ﬁ  xed 24 h later, and ﬂ  uorescence 
was examined with a microscope (Axiovert 200; Carl Zeiss MicroImaging, 
Inc.) using a 20× objective. Digitized images ( 15 cells per coverslip) of 
EYFP ﬂ  uorescence were acquired using a camera (ORCA II ERG; Hama-
matsu) and Wasabi software (Hamamatsu). Overlapping images were 
taken where necessary to encompass the entire process length. Neurite 
length was measured from size-calibrated images using MetaMorph 6.1 
imaging software (Universal Imaging Corp.).
COS-7 cells were transfected using Lipofectamine. For analysis of 
  protein–protein interactions, COS-7 cells were transfected as follows: 50% 
of total DNA as EGFP-tagged stathmin, SCG10, SCLIP, RB3, or RB3′ together 
with 50% of pEBG-JNK. Cells were lysed 48 h after transfection in lysis 
buffer. Precleared supernatants were incubated with S-hexy  lglutathione–
  Sepharose at 4°C. Pull downs were washed (2× lysis buffer, 3 × LiCl wash, 
and 1× lysis buffer), suspended in laemmli buffer, and immunoblotted.
Online supplemental material
Fig. S1 shows characterization of PSCG10 antibody speciﬁ  city for immuno-
staining. Fig. S2 shows magniﬁ   ed views of JNK1, SCG10, and GFAP 
staining in E15 embryo. Fig. S3 shows composite images of YFP-CAAX/
CFP-SCG10 mutant expression in cortical neurons. The supplementary text 
describes reporter gene expression analysis,   immunohistochemistry, im-
munoﬂ   uorescence, subcellular fractionation, and photobleaching pro-
cedures. Online supplemental material is available at http://www.jcb.
org/cgi/content/full/jcb.200511055/DC1.
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